Exact Sciences launches Cancerguard MCED test as laboratory-developed test in US (cancerletter.com)

• Cancerguard launched as an LDT in the US
• Multi-omics blood test for early cancer detection
• Exact Sciences enters MCED market

"Exact Sciences announced the launch of Cancerguard, a multi-cancer early detection blood test, now available as a laboratory-developed test in the United States. The test is intended to detect multiple cancer types from a single blood draw."